The collaboration will see novel therapeutic antibody discovery and CMC process development to produce more effective, safer and affordable treatments. Singapore-based SCG Cell Therapy Pte Ltd...
Sichuan Clover Biopharmaceuticals, Inc partner with CEPI to boost development and manufacturing of its COVID-19 vaccine candidate. The Coalition for Epidemic Preparedness Innovations (CEPI) announced...
Scientists from Duke-NUS Medical School explore the potential use of an individual’s immune cells for therapy against infectious disease. With the recent emergence of the COVID-19 pandemic,...
Holistic integration of human, processes, equipment and space critical in battling against infectious diseases. by Khurram Majeed Four months into 2020 and the world is still reeling from the...
Using STARR technology™ platform developed by Arcturus Therapeutics, Duke-NUS Medical School hopes to conduct rapid screening of vaccines for effectiveness and safety. COVID-19 is caused by the...
Ebola virus, HIV, SARS virus, and just recently, COVID-19 -- we commonly associate viruses with some of the deadliest infections in history. However, did you know that the next “wonder...
Funding round will support Emergex’s pipeline of set-point vaccines for infectious diseases. Based in the United Kingdom, Emergex is a biotechnology company that develops set-point vaccines to...
Breakthrough discovery reveals that Envelope (E) proteins in dengue virus are able to mutate and change its surface structure to evade detection. Colour coded alert posters strategically placed near...
Enables remote diagnosis and treatment for infectious diseases. China's technology hub Shenzhen is about to pilot a new therapeutic program aided by advanced communication technology in infectious...
